PROCEPT BioRobotics (PRCT) News Today → Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way (From Small Cap Sniper) (Ad) Free PRCT Stock Alerts $65.64 +2.14 (+3.37%) (As of 11:27 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 4:39 AM | marketbeat.comVictory Capital Management Inc. Has $9.05 Million Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT)Victory Capital Management Inc. decreased its position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 28.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 216,036 shares of the compMay 13 at 4:05 PM | globenewswire.comPROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock ConferenceMay 11 at 1:16 AM | americanbankingnews.comReviewing PROCEPT BioRobotics (NASDAQ:PRCT) and Hypertension Diagnostics (OTCMKTS:HDII)May 8, 2024 | americanbankingnews.comPROCEPT BioRobotics (NASDAQ:PRCT) PT Raised to $75.00May 8, 2024 | americanbankingnews.comPROCEPT BioRobotics (NASDAQ:PRCT) PT Raised to $75.00 at Piper SandlerMay 7, 2024 | americanbankingnews.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) Director Thomas M. Krummel Sells 20,000 SharesMay 7, 2024 | insidertrades.comThomas M. Krummel Sells 20,000 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) StockMay 7, 2024 | americanbankingnews.comPROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 4.3% After Insider SellingMay 6, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Fulgent Genetics (FLGT), Cigna (CI) and PROCEPT BioRobotics (PRCT)May 6, 2024 | marketbeat.comLisanti Capital Growth LLC Invests $5.10 Million in PROCEPT BioRobotics Co. (NASDAQ:PRCT)Lisanti Capital Growth LLC acquired a new position in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 121,690 shares of the company's stock, valued at approximately $5,100,000. PRMay 6, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and PROCEPT BioRobotics (PRCT)May 6, 2024 | markets.businessinsider.comUnveiling 4 Analyst Insights On PROCEPT BioRoboticsMay 6, 2024 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Given New $75.00 Price Target at TD CowenTD Cowen boosted their target price on shares of PROCEPT BioRobotics from $65.00 to $75.00 and gave the stock a "buy" rating in a research note on Monday.May 6, 2024 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Shares Down 4.3% Following Insider SellingPROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 4.3% on Insider SellingMay 6, 2024 | globenewswire.comReal-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic HyperplasiaMay 6, 2024 | marketbeat.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) Director Thomas M. Krummel Sells 20,000 Shares of StockPROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) Director Thomas M. Krummel sold 20,000 shares of the firm's stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $60.00, for a total transaction of $1,200,000.00. Following the completion of the sale, the director now owns 45,631 shares in the company, valued at $2,737,860. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.May 6, 2024 | americanbankingnews.comBrokers Set Expectations for PROCEPT BioRobotics Co.'s Q2 2024 Earnings (NASDAQ:PRCT)May 5, 2024 | americanbankingnews.comAlaleh Nouri Sells 30,432 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) StockMay 4, 2024 | finance.yahoo.comPROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported And Analysts Have Been Lifting Their Price TargetsMay 4, 2024 | insidertrades.comInsider Selling: PROCEPT BioRobotics Co. (NASDAQ:PRCT) EVP Sells 30,432 Shares of StockMay 4, 2024 | americanbankingnews.comQ2 2024 Earnings Forecast for PROCEPT BioRobotics Co. Issued By William Blair (NASDAQ:PRCT)May 3, 2024 | finance.yahoo.comPROCEPT BioRobotics First Quarter 2024 Earnings: Beats ExpectationsMay 3, 2024 | finance.yahoo.comPROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call TranscriptMay 3, 2024 | marketbeat.comWilliam Blair Equities Analysts Increase Earnings Estimates for PROCEPT BioRobotics Co. (NASDAQ:PRCT)PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) - Stock analysts at William Blair lifted their Q2 2024 earnings per share (EPS) estimates for shares of PROCEPT BioRobotics in a research note issued to investors on Wednesday, May 1st. William Blair analyst B. Vazquez now expects that the compaMay 2, 2024 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPSPROCEPT BioRobotics (NASDAQ:PRCT - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.51) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.04. The company had revenue of $44.50 million during the quarter, compared to analyst estimates of $41.58 million. PROCEPT BioRobotics had a negative net margin of 77.75% and a negative return on equity of 46.59%. PROCEPT BioRobotics's revenue for the quarter was up 82.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.63) EPS.May 2, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Cross Country Healthcare (CCRN) and CVS Health (CVS)May 2, 2024 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Price Target Raised to $72.00Truist Financial raised their price objective on PROCEPT BioRobotics from $63.00 to $72.00 and gave the stock a "buy" rating in a research note on Thursday.May 2, 2024 | finance.yahoo.comPROCEPT BioRobotics Corp (PRCT) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues ...May 1, 2024 | markets.businessinsider.comBuy Rating Affirmed on PROCEPT BioRobotics’ Strong Performance and Promising Growth TrajectoryMay 1, 2024 | investorplace.comPRCT Stock Earnings: PROCEPT BioRobotics Beats EPS, Beats Revenue for Q1 2024May 1, 2024 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Reaches New 52-Week High at $57.23PROCEPT BioRobotics (NASDAQ:PRCT) Hits New 1-Year High at $57.23May 1, 2024 | finance.yahoo.comBiotech Leader Procept BioRobotics Jumps Past Buy Point On EarningsMay 1, 2024 | globenewswire.comPROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue GuidanceApril 30, 2024 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 3.7%PROCEPT BioRobotics (NASDAQ:PRCT) Shares Up 3.7%April 30, 2024 | markets.businessinsider.comHere's what Wall Street expects from PROCEPT BioRobotics's earningsApril 29, 2024 | finance.yahoo.comLate Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic HyperplasiaApril 27, 2024 | marketbeat.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives Consensus Rating of "Buy" from BrokeragesPROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) has been given a consensus recommendation of "Buy" by the six brokerages that are presently covering the stock, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month priceApril 24, 2024 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Reaches New 52-Week High at $54.79PROCEPT BioRobotics (NASDAQ:PRCT) Hits New 52-Week High at $54.79April 24, 2024 | seekingalpha.comPRCT PROCEPT BioRobotics CorporationApril 23, 2024 | globenewswire.comPROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual MeetingApril 18, 2024 | marketbeat.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) Stake Lowered by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC cut its stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 82.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 161,848 shares of the company's stock after sellingApril 15, 2024 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 3.5%PROCEPT BioRobotics (NASDAQ:PRCT) Shares Up 3.5%April 11, 2024 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Reaches New 12-Month High at $53.54PROCEPT BioRobotics (NASDAQ:PRCT) Sets New 1-Year High at $53.54April 8, 2024 | msn.comExperts Top 5 AI Stocks With Huge PotentialApril 5, 2024 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Stock Price Up 4.4%PROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 4.4%April 4, 2024 | globenewswire.comPROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, TexasApril 3, 2024 | marketbeat.comBallentine Partners LLC Purchases Shares of 133,000 PROCEPT BioRobotics Co. (NASDAQ:PRCT)Ballentine Partners LLC acquired a new position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 133,000 shares of the company's stock, valueApril 2, 2024 | globenewswire.comPROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024April 2, 2024 | marketbeat.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives Consensus Rating of "Buy" from AnalystsPROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) has earned a consensus rating of "Buy" from the six analysts that are covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month price objective among analystsMarch 31, 2024 | marketbeat.comBrokers Issue Forecasts for PROCEPT BioRobotics Co.'s Q2 2025 Earnings (NASDAQ:PRCT)PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) - Equities research analysts at Leerink Partnrs issued their Q2 2025 EPS estimates for PROCEPT BioRobotics in a report released on Thursday, March 28th. Leerink Partnrs analyst M. Kratky expects that the company will post earnings of ($0.42) per Get PROCEPT BioRobotics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter. Email Address How to Make 100X on the AI Boom (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market. Click for his six specific AI stock in the crosshairs PRCT Media Mentions By Week PRCT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRCT News Sentiment▼0.360.57▲Average Medical News Sentiment PRCT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRCT Articles This Week▼73▲PRCT Articles Average Week Get PROCEPT BioRobotics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IRTC News Today AXNX News Today TNDM News Today NARI News Today ICUI News Today IART News Today ATEC News Today MMSI News Today LMAT News Today NVCR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRCT) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PROCEPT BioRobotics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
